Skip to content

Researchers develop an artificial enzyme that speeds reactions in living cells.

In the course of evolution, nature has produced thousands of enzymes to facilitate the myriad of chemical reactions taking place inside living organisms every day.  Enzymes are responsible for accelerating or catalyzing reactions in the body that would normally occur extremely slowly or not at all without them. Now, a study from researchers at Paris-Saclay University develops artificial enzymes anchored to the surface of living human cells.  The team states these enzymes could be used for therapeutic purposes, producing pharmacological compounds directly on the surface of specific cells, potentially reducing side effects. The study is published in the Journal of the American Chemical Society.

Previous studies show metalloenzymes are a class of enzyme-containing a metal ion, such as zinc, iron, or copper, to speed up chemical reactions in the body.  Artificial metalloenzymes have been proven in catalysis, however, applications in living cells remain difficult as metabolism by its very nature damages metal ions, preventing the formation of enzymes.  The current study engineers an artificial enzyme capable of catalyzing the Diels-Alder reaction right on the surfaces of living cells. This reaction is used to synthesize drugs, agrochemicals, and many other molecules.

The current study uses a protein called the A2A adenosine receptor, naturally present on the surfaces of some cells in the body, to develop their artificial enzyme. The lab modified a molecule known to bind to this receptor with a copper-containing chemical group for catalyzing the Diels-Alder reaction. Results show the compound attaches to the A2A adenosine receptors on living human cells in vitro, forming an artificial enzyme. Data findings show this enzyme catalyzes the Diels-Alder reaction with a yield of up to fifty percent.

The team states their discovery showing the potential of artificial metalloenzymes associating metal complexes with membrane receptors is a big step forward for in vivo catalysis.  They go on to add these artificial enzymes could be used for the synthesis of either drugs or deficient metabolites, and for the activation of prodrugs, leading to therapeutic tools with unforeseen applications.

The team surmises they have designed artificial enzymes able to sit on the surfaces of living cells and drive reactions no known human enzyme has been able to catalyze before.  For the future, the researchers state artificial enzymes might be designed to bind proteins found only on specific cell types, for example, cancer cells, with the artificial enzyme converting innocuous chemicals into drugs to kill the foreign invader.

Source: American Chemical Society

Get Healthinnovations delivered to your inbox:

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »